Identification of protein methyltransferases 5 associated with ferroptosis and immune cell infiltration of head and...

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Head and neck tumors present significant treatment challenges, with poor prognoses in advanced cases.
• Protein Arginine Methyltransferases (PRMTs) regulate crucial cellular processes and are implicated in tumorigenesis.
• Understanding PRMT family roles is vital for improving head and neck tumor patient survival and quality of life.

Purpose of the Study:

• To investigate the role of the PRMT family in head and neck tumor development and progression.
• To evaluate PRMT5 as a potential prognostic biomarker for head and neck tumors.
• To explore the molecular mechanisms linking PRMT5 to head and neck tumorigenesis.

Main Methods:

• Analysis of PRMT family member expression in head and neck tumors.
• Statistical evaluation of PRMT5 as an independent prognostic factor.
• Bioinformatic analysis of PRMT5-regulated genes and associated signaling pathways (e.g., IL-17, p53).
• Correlation analysis of PRMT5 expression with immune cell infiltration, m6A, ferroptosis, and drug sensitivity.

Main Results:

• PRMT family members are significantly overexpressed in head and neck tumors.
• PRMT5 expression is an independent prognostic factor for head and neck tumors.
• PRMT5-regulated genes are enriched in key tumor-associated signaling pathways.
• PRMT5 expression correlates with immune infiltration, m6A, ferroptosis, and drug sensitivity in head and neck tumors.

Conclusions:

• The PRMT family, particularly PRMT5, plays a significant role in the development of head and neck tumors.
• PRMT5 serves as a potential prognostic biomarker and therapeutic target for head and neck cancer.
• Further research into PRMTs could lead to improved treatment strategies and patient outcomes for head and neck tumors.